Table 1 —

Characteristics of women with NGT and women with IGT

Women with NGTWomen with IGT% Difference
n20346
Physical characteristics
 Age (years)45.7 ± 8.447.4 ± 10.53.7
 Menopausal (%)61 (30)21 (46)*
 Use of HRT (%)27 (44)9 (43)
 BMI (kg/m2)27.2 ± 6.532.6 ± 8.219.9
 Body fat mass (kg)26.7 ± 12.636.6 ± 15.037.1
 Waist circumference (cm)82.5 ± 14.094.9 ± 15.915.0
 Waist-to-hip ratio0.79 ± 0.070.84 ± 0.076.3
 Computed tomography abdominal AT areas (cm2)
  Total443 ± 211605 ± 22436.6
  Visceral103 ± 51151 ± 5146.6
  Subcutaneous340 ± 170454 ± 19233.5
Lipoprotein profile
 Cholesterol (mmol/l)
  Total5.09 ± 0.895.63 ± 0.97§10.6
  VLDL0.41 ± 0.280.65 ± 0.3358.5
  LDL3.36 ± 0.813.76 ± 0.8711.9
  HDL1.30 ± 0.331.20 ± 0.25#–7.7
  HDL20.52 ± 0.220.45 ± 0.16–13.5
  HDL30.74 ± 0.150.75 ± 0.151.4
 Cholesterol/HDL-cholesterol4.13 ± 1.164.87 ± 1.3017.9
 HDL2/HDL30.71 ± 0.280.61 ± 0.21–14.1
 Triglycerides (mmol/l)1.27 ± 0.612.03 ± 0.8259.8
 Apo B (g/l)0.95 ± 0.221.12 ± 0.2617.9
 Apo A-I (g/l)1.28 ± 0.201.31 ± 0.202.3
 LDL peak particle size (Å)**254.7 ± 4.2253.1 ± 3.2#–0.6
Insulin-glucose homeostatis
 Fasting glucose (mmol/l)4.97 ± 0.415.44 ± 0.549.5
 Fasting insulin (pmol/l)57.1 ± 40.6106.3 ± 72.286.2
 Fasting C-peptide (pmol/l)693.2 ± 300.5995.2 ± 404.343.6
 Glucose area (× 10–3 mmol/l)1.09 ± 0.161.53 ± 0.1840.4
 Insulin area (× 10–3 pmol/l)69.0 ± 37.6133.7 ± 98.993.8
 C-peptide area (× 10–3 pmol/l)479.4 ± 185.4664.1 ± 251.938.5
 2-h post-OGTT glucose (mmol/l)5.70 ± 1.068.98 ± 0.9657.5
Blood pressure (mmHg)
 Systolic115 ± 13123 ± 21#10.0
 Diastolic74 ± 977 ± 10#4.1
  • Data are means ± SD unless otherwise indicated.

  • *

    * P < 0.05;

  • expressed as a percentage of menopausal women;

  • significantly different between women with NGT versus women with IGT, P < 0.0001;

  • §

    § P < 0.001;

  • n = 174 in women with NGT and n = 41 in women with IGT;

  • P < 0.01;

  • #

    # P < 0.05;

  • **

    ** n = 113 in women with NGT and n = 29 in women with IGT.